亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

The Challenge of Intermediate-Risk Pulmonary Embolism

医学 肺栓塞 重症监护医学 心脏病学 内科学
作者
Spencer F. Weintraub,Joseph You,Sean R. Wilson,Andrew Galmer
出处
期刊:American Journal of Therapeutics [Lippincott Williams & Wilkins]
卷期号:30 (2): e134-e144 被引量:1
标识
DOI:10.1097/mjt.0000000000001605
摘要

Intermediate-risk pulmonary embolism is a common disease that is associated with significant morbidity and mortality; however, a standardized treatment protocol is not well-established.Treatments available for intermediate-risk pulmonary embolisms include anticoagulation, systemic thrombolytics, catheter-directed therapies, surgical embolectomy, and extracorporeal membrane oxygenation. Despite these options, there is no clear consensus on the optimal indication and timing of these interventions.Anticoagulation remains the cornerstone of treatment for pulmonary embolism; however, over the past 2 decades, there have been advances in the safety and efficacy of catheter-directed therapies. For massive pulmonary embolism, systemic thrombolytics and, sometimes, surgical thrombectomy are considered first-line treatments. Patients with intermediate-risk pulmonary embolism are at high risk of clinical deterioration; however, it is unclear whether anticoagulation alone is sufficient. The optimal treatment of intermediate-risk pulmonary embolism in the setting of hemodynamic stability with right heart strain present is not well-defined. Therapies such as catheter-directed thrombolysis and suction thrombectomy are being investigated given their potential to offload right ventricular strain. Several studies have recently evaluated catheter-directed thrombolysis and embolectomies and demonstrated the efficacy and safety of these interventions. Here, we review the literature on the management of intermediate-risk pulmonary embolisms and the evidence behind those interventions.There are many treatments available in the management of intermediate-risk pulmonary embolism. Although the current literature does not favor 1 treatment as superior, multiple studies have shown growing data to support catheter-directed therapies as potential options for these patients. Multidisciplinary pulmonary embolism response teams remain a key feature in improving the selection of advanced therapies and optimization of care.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
上官若男应助科研通管家采纳,获得10
1分钟前
ZJakariae应助科研通管家采纳,获得10
1分钟前
1分钟前
曹大壮发布了新的文献求助10
1分钟前
1分钟前
123发布了新的文献求助10
2分钟前
widesky777完成签到 ,获得积分0
2分钟前
沐雨篱边完成签到 ,获得积分10
2分钟前
nojego完成签到,获得积分20
2分钟前
曹大壮完成签到,获得积分10
2分钟前
2分钟前
快乐小狗发布了新的文献求助10
2分钟前
77发布了新的文献求助30
3分钟前
JamesPei应助嘟嘟采纳,获得10
3分钟前
3分钟前
嘟嘟发布了新的文献求助10
4分钟前
4分钟前
111完成签到 ,获得积分10
4分钟前
小胡发布了新的文献求助10
4分钟前
快乐小狗发布了新的文献求助10
5分钟前
科研通AI5应助科研通管家采纳,获得10
5分钟前
科研通AI5应助科研通管家采纳,获得30
5分钟前
席江海完成签到,获得积分10
5分钟前
SciGPT应助咕咕采纳,获得10
6分钟前
豌豆完成签到 ,获得积分10
6分钟前
6分钟前
6分钟前
共享精神应助小胡采纳,获得10
6分钟前
Hello应助咕咕采纳,获得10
6分钟前
nine2652完成签到 ,获得积分10
6分钟前
7分钟前
7分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
yindi1991完成签到 ,获得积分10
7分钟前
8分钟前
嘟嘟发布了新的文献求助10
8分钟前
嘟嘟完成签到,获得积分20
8分钟前
一只大榴莲完成签到,获得积分10
9分钟前
充电宝应助科研通管家采纳,获得10
9分钟前
所所应助科研通管家采纳,获得10
9分钟前
高分求助中
Technologies supporting mass customization of apparel: A pilot project 600
Izeltabart tapatansine - AdisInsight 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
Epigenetic Drug Discovery 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3815818
求助须知:如何正确求助?哪些是违规求助? 3359386
关于积分的说明 10402289
捐赠科研通 3077196
什么是DOI,文献DOI怎么找? 1690236
邀请新用户注册赠送积分活动 813659
科研通“疑难数据库(出版商)”最低求助积分说明 767728